journal article·2020-10-12Open access

Development of an N-Cadherin Biofunctionalized Hydrogel to Support the Formation of Synaptically Connected Neural Networks

Brian J. O’Grady, Kylie M. Balotin, Allison M. Bosworth, P. Mason McClatchey, Robert M. Weinstein, Mukesh Gupta, Kara S. Poole, Leon M. Bellan, Ethan S. Lippmann

Abstract

In vitro models of the human central nervous system (CNS), particularly those derived from induced pluripotent stem cells (iPSCs), are becoming increasingly recognized as useful complements to animal models for studying neurological diseases and developing therapeutic strategies. However, many current three-dimensional (3D) CNS models suffer from deficits that limit their research utility. In this work, we focused on improving the interactions between the extracellular matrix (ECM) and iPSC-derived neurons to support model development. The most common ECMs used to fabricate 3D CNS models often lack the necessary bioinstructive cues to drive iPSC-derived neurons to a mature and synaptically connected state. These ECMs are also typically difficult to pattern into complex structures due to their mechanical properties. To address these issues, we functionalized gelatin methacrylate (GelMA) with an N-cadherin (Cad) extracellular peptide epitope to create a biomaterial termed GelMA-Cad. After photopolymerization, GelMA-Cad forms soft hydrogels (on the order of 2 kPa) that can maintain patterned architectures. The N-cadherin functionality promotes survival and maturation of single-cell suspensions of iPSC-derived glutamatergic neurons into synaptically connected networks as determined by viral tracing and electrophysiology. Immunostaining reveals a pronounced increase in presynaptic and postsynaptic marker expression in GelMA-Cad relative to Matrigel, as well as extensive colocalization of these markers, thus highlighting the biological activity of the N-cadherin peptide. Overall, given its ability to enhance iPSC-derived neuron maturity and connectivity, GelMA-Cad should be broadly useful for in vitro studies of neural circuitry in health and disease.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: 3D Printing in Biomedical Research · Neuroscience and Neural Engineering · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

Interdisciplinary Materials Science Program, Vanderbilt University, Nashville, Tennessee 37235, United States

Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37235, United States

Department of Mechanical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States

Vanderbilt Brain Institute, Vanderbilt University, Nashville, Tennessee 37235, United States

Department of Neurology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States

Funding

National Institute of Neurological Disorders and Stroke · National Institute of Diabetes and Digestive and Kidney Diseases · National Institute of Biomedical Imaging and Bioengineering · Brain and Behavior Research Foundation · Division of Civil, Mechanical and Manufacturing Innovation · Division of Chemical, Bioengineering, Environmental, and Transport Systems · Division of Materials Research · BrightFocus Foundation · Chan Zuckerberg Initiative

References (73)

Show source-provided references
1. 10.1002/jnr.2437910.1002/jnr.24379 ↗
2. 10.1080/13543784.2017.132386810.1080/13543784.2017.1323868 ↗
3. 10.1016/j.nhtm.2014.08.00110.1016/j.nhtm.2014.08.001 ↗
4. 10.1002/bies.20170008910.1002/bies.201700089 ↗
5. 10.1016/j.biomaterials.2013.11.02810.1016/j.biomaterials.2013.11.028 ↗
6. 10.1080/0036551070146641610.1080/00365510701466416 ↗
7. 10.3892/or.2015.376710.3892/or.2015.3767 ↗
8. 10.1016/j.biomaterials.2017.10.00210.1016/j.biomaterials.2017.10.002 ↗
9. 10.1038/nature1251710.1038/nature12517 ↗
10. 10.1038/nrn.2017.10710.1038/nrn.2017.107 ↗
11. Long K. R. · 2019 · 9
12. 10.1002/pmic.20090075810.1002/pmic.200900758 ↗
13. 10.1016/j.biomaterials.2013.04.04210.1016/j.biomaterials.2013.04.042 ↗
14. 10.1038/ncb331210.1038/ncb3312 ↗
15. 10.3389/fnsyn.2018.0001510.3389/fnsyn.2018.00015 ↗
16. 10.1021/acsbiomaterials.8b0062210.1021/acsbiomaterials.8b00622 ↗
17. 10.5114/fn.2017.6857810.5114/fn.2017.68578 ↗
18. 10.1073/pnas.152125511310.1073/pnas.1521255113 ↗
19. 10.1177/153537021771502810.1177/1535370217715028 ↗
20. 10.1038/nmat502010.1038/nmat5020 ↗
21. 10.1063/1.504512410.1063/1.5045124 ↗
22. 10.1016/j.tibtech.2016.01.00210.1016/j.tibtech.2016.01.002 ↗
23. 10.1371/journal.pone.011934010.1371/journal.pone.0119340 ↗
24. 10.1016/j.biomaterials.2013.06.02510.1016/j.biomaterials.2013.06.025 ↗
25. 10.3791/5297010.3791/52970 ↗
26. 10.1586/erd.11.2710.1586/erd.11.27 ↗
27. 10.1021/acsami.7b1819710.1021/acsami.7b18197 ↗
28. 10.1089/ten.tec.2015.017910.1089/ten.tec.2015.0179 ↗
29. 10.1016/j.biomaterials.2010.03.06410.1016/j.biomaterials.2010.03.064 ↗
30. 10.1073/pnas.121410011010.1073/pnas.1214100110 ↗
31. 10.1038/srep0680110.1038/srep06801 ↗
32. 10.1002/stem.162210.1002/stem.1622 ↗
33. 10.1038/nprot.2012.11610.1038/nprot.2012.116 ↗
34. 10.1038/nbt.152910.1038/nbt.1529 ↗
35. 10.1038/nprot.2016.03710.1038/nprot.2016.037 ↗
36. 10.3390/polym808026910.3390/polym8080269 ↗
37. 10.3390/ma910079710.3390/ma9100797 ↗
38. 10.1182/blood-2010-11-32112510.1182/blood-2010-11-321125 ↗
39. 10.1111/micc.1248210.1111/micc.12482 ↗
40. 10.1016/j.mito.2015.12.00310.1016/j.mito.2015.12.003 ↗
41. 10.1371/journal.pone.013517010.1371/journal.pone.0135170 ↗
42. 10.1016/j.ydbio.2006.12.01410.1016/j.ydbio.2006.12.014 ↗
43. 10.1101/cshperspect.a02930610.1101/cshperspect.a029306 ↗
44. 10.1523/JNEUROSCI.1266-15.201510.1523/JNEUROSCI.1266-15.2015 ↗
45. 10.4161/cib.4.3.1488610.4161/cib.4.3.14886 ↗
46. 10.1073/pnas.161521511410.1073/pnas.1615215114 ↗
47. 10.1016/j.biomaterials.2015.08.04510.1016/j.biomaterials.2015.08.045 ↗
48. 10.1016/S0021-9290(00)00120-210.1016/S0021-9290(00)00120-2 ↗
49. Hirakawa K. · No To Shinkei · 1981 · 33 · 1057
50. 10.1039/C4LC00030G10.1039/C4LC00030G ↗
51. 10.1002/cyto.a.2089510.1002/cyto.a.20895 ↗
52. 10.1007/s12021-008-9010-510.1007/s12021-008-9010-5 ↗
53. 10.1016/j.neuro.2008.02.01110.1016/j.neuro.2008.02.011 ↗
54. 10.1038/srep2618110.1038/srep26181 ↗
55. 10.7554/eLife.1238710.7554/eLife.12387 ↗
56. 10.1016/bs.ctdb.2018.02.00210.1016/bs.ctdb.2018.02.002 ↗
57. 10.1038/srep0181710.1038/srep01817 ↗
58. 10.1002/stem.74610.1002/stem.746 ↗
59. 10.1016/j.stemcr.2020.05.00310.1016/j.stemcr.2020.05.003 ↗
60. 10.1038/nmeth.341510.1038/nmeth.3415 ↗
61. 10.1021/acsbiomaterials.6b0074510.1021/acsbiomaterials.6b00745 ↗
62. 10.1016/j.actbio.2014.06.00110.1016/j.actbio.2014.06.001 ↗
63. 10.1016/0896-6273(88)90207-310.1016/0896-6273(88)90207-3 ↗
64. 10.1016/S0896-6273(02)00748-110.1016/S0896-6273(02)00748-1 ↗
65. 10.1073/pnas.100348010710.1073/pnas.1003480107 ↗
66. 10.1186/s12929-018-0491-810.1186/s12929-018-0491-8 ↗
67. 10.1038/nmat400910.1038/nmat4009 ↗
68. 10.1016/j.jsb.2009.05.00510.1016/j.jsb.2009.05.005 ↗
69. 10.1002/jbm.a.3483510.1002/jbm.a.34835 ↗
70. 10.1016/j.biomaterials.2015.11.05910.1016/j.biomaterials.2015.11.059 ↗
71. 10.1016/j.msec.2017.11.02010.1016/j.msec.2017.11.020 ↗
72. 10.1016/j.biomaterials.2019.01.01710.1016/j.biomaterials.2019.01.017 ↗
73. 10.1002/pat.444210.1002/pat.4442 ↗